Skip to main content
Acta Pharmaceutica Sinica. B logoLink to Acta Pharmaceutica Sinica. B
. 2024 Feb 29;14(5):2359–2360. doi: 10.1016/j.apsb.2024.02.021

Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics’ [Acta Pharm Sin B 12 (2022) 4458–4471]

Qiang Niu a,, Yu Liu b,, Yujing Zheng b,, Ziwei Tang a, Yuna Qian b,c, Ruogu Qi d,, Jianliang Shen b,c,, Ping Zhao a,
PMCID: PMC11120278  PMID: 38799635

The authors regret that there is an error in Fig. 6 in the article due to the mistake of copying and pasting in the process of assembling figures and negligence in the proofreading. Although it does not affect the conclusion, it is an obvious error. The authors have now modified as below. The authors apologize for any inconvenience caused to the journal and readers.

Fig. 6 is revised as:

Image 1

Footnotes

Peer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.

Contributor Information

Ruogu Qi, Email: rqi@njucm.edu.cn.

Jianliang Shen, Email: shenjl@wiucas.ac.cn.

Ping Zhao, Email: pingzhao@gdpu.edu.cn.


Articles from Acta Pharmaceutica Sinica. B are provided here courtesy of Elsevier

RESOURCES